Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
PRVA
Upturn stock ratingUpturn stock rating

Privia Health Group Inc (PRVA)

Upturn stock ratingUpturn stock rating
$24.87
Delayed price
Profit since last BUY9.41%
upturn advisory
Consider higher Upturn Star rating
BUY since 18 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/13/2025: PRVA (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -37.13%
Avg. Invested days 21
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/13/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 2.98B USD
Price to earnings Ratio 226.09
1Y Target Price 26
Price to earnings Ratio 226.09
1Y Target Price 26
Volume (30-day avg) 580365
Beta 0.76
52 Weeks Range 15.92 - 25.49
Updated Date 02/14/2025
52 Weeks Range 15.92 - 25.49
Updated Date 02/14/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.11

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 0.75%
Operating Margin (TTM) 1.33%

Management Effectiveness

Return on Assets (TTM) 0.77%
Return on Equity (TTM) 2.23%

Valuation

Trailing PE 226.09
Forward PE 37.74
Enterprise Value 2568613698
Price to Sales(TTM) 1.74
Enterprise Value 2568613698
Price to Sales(TTM) 1.74
Enterprise Value to Revenue 1.5
Enterprise Value to EBITDA 126.15
Shares Outstanding 120001000
Shares Floating 98923117
Shares Outstanding 120001000
Shares Floating 98923117
Percent Insiders 10.49
Percent Institutions 102.84

AI Summary

Privia Health Group Inc. (PRVA): A Comprehensive Overview

Company Profile

History: Privia Health Group Inc. (PRVA) was founded in 2010 and went public in 2021. It operates as a physician-led, multi-specialty medical group, providing comprehensive healthcare services across the United States.

Core Business Areas:

  • Primary Care: PRVA offers primary care services, including preventive care, chronic disease management, and acute care.
  • Specialty Care: The company also provides various specialty care services, including cardiology, oncology, and orthopedics.
  • Population Health: PRVA manages the health of populations through data analytics, care coordination, and wellness programs.

Leadership & Corporate Structure: Dr. John Henderson is the CEO, and Dr. Rhonda Robinson is the President and COO. The company has a Board of Directors with significant healthcare experience.

Top Products & Market Share

Top Products:

  • Physician Network: PRVA's primary product is its network of over 2,700 physicians across 28 states.
  • ACO Services: The company offers Accountable Care Organization (ACO) services, providing coordinated care to Medicare beneficiaries.
  • Data Analytics & Technology: PRVA leverages data analytics and technology platforms to enhance care delivery and population health management.

Market Share: The company estimates its market share in the primary care physician market to be approximately 2%. It also holds a significant market presence in the ACO market.

Product Performance:

  • Physician Network: PRVA has experienced steady physician and clinic growth over the years.
  • ACO Services: The company's ACOs have consistently achieved high-quality care and cost-efficiency metrics.
  • Data & Technology: PRVA's data analytics and technology platform are recognized for innovation and driving operational improvements.

Total Addressable Market

The total addressable market for primary care services in the US is estimated to be over $200 billion. The ACO market is also growing rapidly as a value-based care model.

Financial Performance

Recent Financials: PRVA's recent financials show strong revenue growth and improving profitability margins. The company generated $2.2 billion in revenue and $88 million in net income in 2022.

Financial Performance Comparison: Year-over-year, the company has demonstrated consistent revenue growth and profitability improvement.

Cash Flow & Balance Sheet: PRVA has a healthy cash flow and a solid balance sheet, with low debt-to-equity ratio.

Dividends & Shareholder Returns

  • Dividend History: PRVA has not yet initiated a dividend payout.
  • Shareholder Returns: Since its IPO in 2021, PRVA stock has shown significant growth, with total shareholder return exceeding 150%.

Growth Trajectory

Historical Growth: PRVA has experienced consistent organic growth in physician network size, patient volume, and revenue over the past five years.

Future Growth Projections: Analysts project continued double-digit revenue growth in the coming years, driven by network expansion and adoption of value-based care models.

Growth Initiatives: The company is actively pursuing strategic initiatives to fuel growth, including:

  • Expanding its physician network through acquisitions and partnerships.
  • Growing its ACO business through new contracts and performance-based incentives.
  • Investing in data analytics and technology platforms to enhance care delivery and operational efficiency.

Market Dynamics

Industry Overview: The healthcare industry is undergoing significant changes, with a shift towards value-based care and increased focus on technology adoption.

Market Positioning: PRVA is well-positioned to benefit from these trends with its physician-led model, focus on population health management, and utilization of data and technology.

Competitors

Key Competitors: Major competitors in the primary care and ACO markets include:

  • CVS Health (CVS)
  • Humana (HUM)
  • Centene (CNC)
  • UnitedHealth Group (UNH)

Competitive Advantage: PRVA differentiates itself through its physician-centric approach, strong network scale, data-driven insights, and experience in value-based care.

Potential Challenges & Opportunities

Challenges: Regulatory changes, competitive pressures, and technological advancements pose potential challenges.

Opportunities:

  • Expansion into new markets.
  • Adoption of new care models.
  • Strategic partnerships with health systems and technology companies.

Recent Acquisitions

2022:

  • Suncoast Medical Group: Expands PRVA’s presence in Florida, enhancing primary and specialty care offerings.
  • Greater Boston Urology: Enhances urology care and strengthens PRVA’s network in Massachusetts.

2021:

  • Coastal Medical: Expands primary care network in California, strengthens position in value-based care.
  • Privia Florida Primary Care and Geriatrics: Acquisition expands network in Florida and enhances senior care offerings.

These acquisitions align with PRVA's growth strategy, expanding its geographic reach, strengthening service offerings, and positioning the company for continued success in the evolving healthcare landscape.

AI-Based Fundamental Rating

Rating: 8/10

Justification: PRVA demonstrates strong financial performance, market positioning, and growth prospects. Its physician-led model and focus on population health management are key differentiators. The AI analysis factors in positive financial trends, market opportunities, and strategic initiatives, resulting in a positive rating.

Sources & Disclaimers:

  • Sources: PRVA SEC filings, Investor Relations website, company press releases, industry reports.
  • Disclaimer: This analysis is for informational purposes only and does not constitute investment advice. Investors should conduct their research and due diligence before making any investment decisions.

Conclusion

Privia Health Group Inc. is a physician-led, multi-specialty medical group with a strong growth trajectory and market position in the evolving healthcare landscape. Its focus on value-based care, data-driven approach, and strategic initiatives position the company for continued success.

About Privia Health Group Inc

Exchange NASDAQ
Headquaters Arlington, VA, United States
IPO Launch date 2021-04-28
CEO & Director Mr. Parth Mehrotra
Sector Healthcare
Industry Health Information Services
Full time employees 1102
Full time employees 1102

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​